NewSquare Capital’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

NewSquare Capital’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-80	Closed	-$70	–	937
2023 Q2	$70	Hold	80	–	–	﹤0.01%	809
2023 Q1	$56	Hold	80	–	–	﹤0.01%	847
2022 Q4	$66	Buy	+80	New	+$79	﹤0.01%	787

NewSquare Capital's SURF Position: Q3 2023 in Review

NewSquare Capital sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 80 shares — an estimated $70 sold.

NewSquare Capital first reported a position in SURF in Q4 2022 and held it in 3 quarters. The position peaked at $70 in Q2 2023. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

NewSquare Capital reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
NewSquare Capital sold 80 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $70.
NewSquare Capital first reported a position in Surface Oncology, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
NewSquare Capital's Surface Oncology, Inc. Common Stock position peaked at $70 in Q2 2023.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.